HTG Molecular Diagnostics Stock Price, News & Analysis (NASDAQ:HTGM)

$5.06 +0.01 (+0.20 %)
(As of 02/20/2018 04:50 AM ET)
Previous Close$5.06
Today's Range$4.75 - $5.47
52-Week Range$1.20 - $13.25
Volume2.08 million shs
Average Volume2.50 million shs
Market Capitalization$70.48 million
P/E Ratio-1.98
Dividend YieldN/A
BetaN/A

About HTG Molecular Diagnostics (NASDAQ:HTGM)

HTG Molecular Diagnostics logoHTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.

Receive HTGM News and Ratings via Email

Sign-up to receive the latest news and ratings for HTGM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Diagnostic & Testing Equipment
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:HTGM
CUSIPN/A
Phone877-289-2615

Debt

Debt-to-Equity RatioN/A
Current Ratio1.03%
Quick Ratio0.94%

Price-To-Earnings

Trailing P/E Ratio-1.9843137254902
Forward P/E Ratio-2.68
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.13 million
Price / Sales25.67
Cash FlowN/A
Price / CashN/A
Book Value($0.79) per share
Price / Book-6.41

Profitability

Trailing EPS($2.55)
Net Income$-26,030,000.00
Net Margins-273.17%
Return on EquityN/A
Return on Assets-136.22%

Miscellaneous

Employees85
Outstanding Shares26,030,000

HTG Molecular Diagnostics (NASDAQ:HTGM) Frequently Asked Questions

What is HTG Molecular Diagnostics' stock symbol?

HTG Molecular Diagnostics trades on the NASDAQ under the ticker symbol "HTGM."

How were HTG Molecular Diagnostics' earnings last quarter?

HTG Molecular Diagnostics Inc (NASDAQ:HTGM) issued its earnings results on Tuesday, August, 8th. The medical research company reported ($0.60) EPS for the quarter, hitting the consensus estimate of ($0.60). The medical research company earned $1.76 million during the quarter, compared to the consensus estimate of $1.80 million. View HTG Molecular Diagnostics' Earnings History.

When will HTG Molecular Diagnostics make its next earnings announcement?

HTG Molecular Diagnostics is scheduled to release their next quarterly earnings announcement on Monday, May, 14th 2018. View Earnings Estimates for HTG Molecular Diagnostics.

Where is HTG Molecular Diagnostics' stock going? Where will HTG Molecular Diagnostics' stock price be in 2018?

3 Wall Street analysts have issued 1 year target prices for HTG Molecular Diagnostics' shares. Their predictions range from $5.00 to $6.00. On average, they anticipate HTG Molecular Diagnostics' share price to reach $5.67 in the next twelve months. View Analyst Ratings for HTG Molecular Diagnostics.

Who are some of HTG Molecular Diagnostics' key competitors?

Who are HTG Molecular Diagnostics' key executives?

HTG Molecular Diagnostics' management team includes the folowing people:

  • Ann F. Hanham Ph.D., Independent Chairman of the Board (Age 64)
  • Timothy B. Johnson, President, Chief Executive Officer, Director (Age 55)
  • Shaun D. McMeans, Vice President of Finance and Administration, Chief Financial Officer (Age 55)
  • Patrick C. Roche Ph.D., Senior Vice President - Research and Product Development (Age 64)
  • Debra A. Gordon Ph.D. J.D., Vice President, Chief Legal Counsel and Secretary (Age 57)
  • John L. Lubniewski, Chief Business Officer (Age 53)
  • Donnie M. Hardison, Director (Age 66)
  • Harry A. George, Independent Director (Age 68)
  • James T. LaFrance, Independent Director (Age 58)
  • Lee Roy McCracken, Independent Director (Age 59)

When did HTG Molecular Diagnostics IPO?

(HTGM) raised $50 million in an initial public offering (IPO) on Wednesday, May 6th 2015. The company issued 3,600,000 shares at a price of $13.00-$15.00 per share. Leerink Partners served as the underwriter for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Who owns HTG Molecular Diagnostics stock?

HTG Molecular Diagnostics' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include STONEPINE CAPITAL MANAGEMENT, LLC (5.60%) and Private Wealth Partners LLC (1.34%). Company insiders that own HTG Molecular Diagnostics stock include Debra A Gordon, Holdings A/S Novo, John L Lubniewski, Patrick C Roche, Plc Glaxosmithkline, Shaun D Mcmeans and Tim B Johnson. View Institutional Ownership Trends for HTG Molecular Diagnostics.

Who bought HTG Molecular Diagnostics stock? Who is buying HTG Molecular Diagnostics stock?

HTG Molecular Diagnostics' stock was acquired by a variety of institutional investors in the last quarter, including Private Wealth Partners LLC. View Insider Buying and Selling for HTG Molecular Diagnostics.

How do I buy HTG Molecular Diagnostics stock?

Shares of HTG Molecular Diagnostics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HTG Molecular Diagnostics' stock price today?

One share of HTG Molecular Diagnostics stock can currently be purchased for approximately $5.06.

How big of a company is HTG Molecular Diagnostics?

HTG Molecular Diagnostics has a market capitalization of $70.48 million and generates $5.13 million in revenue each year. The medical research company earns $-26,030,000.00 in net income (profit) each year or ($2.55) on an earnings per share basis. HTG Molecular Diagnostics employs 85 workers across the globe.

How can I contact HTG Molecular Diagnostics?

HTG Molecular Diagnostics' mailing address is 3430 E Global Loop, TUCSON, AZ 85706-5009, United States. The medical research company can be reached via phone at 877-289-2615.


MarketBeat Community Rating for HTG Molecular Diagnostics (HTGM)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  136 (Vote Outperform)
Underperform Votes:  118 (Vote Underperform)
Total Votes:  254
MarketBeat's community ratings are surveys of what our community members think about HTG Molecular Diagnostics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

HTG Molecular Diagnostics (NASDAQ:HTGM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.672.67
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.67$5.67$6.17$6.17
Price Target Upside: 58.73% upside40.61% upside175.30% upside168.12% upside

HTG Molecular Diagnostics (NASDAQ:HTGM) Consensus Price Target History

Price Target History for HTG Molecular Diagnostics (NASDAQ:HTGM)

HTG Molecular Diagnostics (NASDAQ:HTGM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/1/2018HC WainwrightReiterated RatingBuy$6.00MediumView Rating Details
1/5/2018Canaccord GenuityBoost Price Target$5.00LowView Rating Details
5/16/2017Rodman & RenshawBoost Price TargetBuy -> Buy$4.50 -> $6.00HighView Rating Details
3/28/2016Leerink SwannReiterated RatingOutperform$10.00 -> $5.00N/AView Rating Details
(Data available from 2/20/2016 forward)

Earnings

HTG Molecular Diagnostics (NASDAQ:HTGM) Earnings History and Estimates Chart

Earnings by Quarter for HTG Molecular Diagnostics (NASDAQ:HTGM)

HTG Molecular Diagnostics (NASDAQ HTGM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/14/2018N/AView Earnings Details
11/7/2017Q3 2017($0.49)($0.46)$3.20 million$3.72 millionViewN/AView Earnings Details
8/8/2017Q2($0.60)($0.60)$1.80 million$1.76 millionViewListenView Earnings Details
5/15/2017Q1($0.58)($0.73)$2.44 million$1.37 millionViewN/AView Earnings Details
3/23/2017Q4 2016($0.79)($0.76)$2.22 million$1.46 millionViewN/AView Earnings Details
11/14/2016Q3 2016($0.87)($0.92)$2.05 million$0.91 millionViewListenView Earnings Details
8/9/2016Q2($0.95)($0.98)$1.90 millionViewListenView Earnings Details
5/12/2016Q1($0.83)($1.02)$1.23 million$0.87 millionViewListenView Earnings Details
3/24/2016Q4($0.79)($0.83)$1.31 million$1.22 millionViewListenView Earnings Details
11/12/2015Q315($0.85)($0.76)$1.07 million$1.00 millionViewListenView Earnings Details
8/6/2015Q215($0.71)($1.73)$1.01 million$0.79 millionViewListenView Earnings Details
6/1/2015Q115($14.99)$1.00 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

HTG Molecular Diagnostics (NASDAQ:HTGM) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.89 EPS
Next Year EPS Consensus Estimate: $-0.6 EPS

Dividends

Dividend History for HTG Molecular Diagnostics (NASDAQ:HTGM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

HTG Molecular Diagnostics (NASDAQ HTGM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.60%
Institutional Ownership Percentage: 7.94%
Insider Trades by Quarter for HTG Molecular Diagnostics (NASDAQ:HTGM)
Institutional Ownership by Quarter for HTG Molecular Diagnostics (NASDAQ:HTGM)

HTG Molecular Diagnostics (NASDAQ HTGM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2017Shaun D McmeansVPSell945$2.11$1,993.95View SEC Filing  
11/1/2017Shaun D McmeansCFOSell945$2.26$2,135.7043,248View SEC Filing  
10/16/2017Shaun D McmeansVPSell946$2.27$2,147.4244,193View SEC Filing  
8/25/2017Holdings A/S NovoMajor ShareholderSell1,149,813$1.81$2,081,161.53View SEC Filing  
8/24/2017Holdings A/S NovoMajor ShareholderSell382,437$1.91$730,454.67View SEC Filing  
8/23/2017Holdings A/S NovoMajor ShareholderSell47,162$2.02$95,267.24View SEC Filing  
8/22/2017Holdings A/S NovoMajor ShareholderSell80,586$2.07$166,813.021,225,085View SEC Filing  
3/27/2017Plc GlaxosmithklineInsiderSell300,000$10.15$3,045,000.00View SEC Filing  
4/4/2016Debra A GordonVPSell1,672$2.89$4,832.0817,705View SEC Filing  
4/4/2016John L LubniewskiInsiderSell796$2.89$2,300.4425,114View SEC Filing  
4/4/2016Shaun D McmeansCFOSell1,601$2.89$4,626.8920,151View SEC Filing  
4/4/2016Tim B JohnsonCEOSell4,914$2.89$14,201.4651,309View SEC Filing  
3/14/2016Debra A GordonVPSell5,535$2.38$13,173.3023,518View SEC Filing  
3/14/2016John L LubniewskiInsiderSell6,889$2.38$16,395.8231,200View SEC Filing  
3/14/2016Patrick C RocheSVPSell5,929$2.38$14,111.0223,783View SEC Filing  
3/14/2016Shaun D McmeansCFOSell5,651$2.38$13,449.3825,991View SEC Filing  
3/14/2016Tim B JohnsonCEOSell10,621$2.38$25,277.9863,964View SEC Filing  
3/9/2016Debra A GordonVPSell3,256$2.69$8,758.6424,729View SEC Filing  
3/9/2016John L LubniewskiInsiderSell4,067$2.69$10,940.2332,712View SEC Filing  
3/9/2016Patrick C RocheSVPSell3,491$2.69$9,390.7925,081View SEC Filing  
3/9/2016Shaun D McmeansCFOSell3,325$2.69$8,944.2527,228View SEC Filing  
3/9/2016Tim B JohnsonCEOSell6,299$2.69$16,944.3166,306View SEC Filing  
8/24/2015Debra A GordonVPBuy1,000$5.16$5,160.001,356View SEC Filing  
8/18/2015Patrick C. RocheSVPBuy6,500$5.76$37,440.006,500View SEC Filing  
8/11/2015John L LubniewskiInsiderBuy5,000$7.67$38,350.00View SEC Filing  
5/11/2015A/S NovoMajor ShareholderBuy365,106$14.00$5,111,484.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

HTG Molecular Diagnostics (NASDAQ HTGM) News Headlines

Source:
DateHeadline
4 Stocks to Watch on News & Technical Momentum4 Stocks to Watch on News & Technical Momentum
www.nasdaq.com - February 14 at 4:04 PM
HTG Molecular Diagnostics to Present at the LEERINK Partners 7th Annual Global Healthcare ConferenceHTG Molecular Diagnostics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - February 7 at 9:40 AM
HC Wainwright Analysts Give HTG Molecular Diagnostics (HTGM) a $6.00 Price TargetHC Wainwright Analysts Give HTG Molecular Diagnostics (HTGM) a $6.00 Price Target
www.americanbankingnews.com - January 28 at 5:10 PM
HTG Molecular Diagnostics (HTGM) Stock Rating Upgraded by Zacks Investment ResearchHTG Molecular Diagnostics (HTGM) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - January 28 at 11:06 AM
HTG Molecular Diagnostics (HTGM) Rating Lowered to Hold at Zacks Investment ResearchHTG Molecular Diagnostics (HTGM) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - January 27 at 5:30 PM
HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional SharesHTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - January 23 at 5:26 PM
HTG Molecular Diagnostics (HTGM) Prices 12M Share Common Offering at $2.90/ShHTG Molecular Diagnostics (HTGM) Prices 12M Share Common Offering at $2.90/Sh
www.streetinsider.com - January 21 at 5:16 PM
HTG Molecular Diagnostics Announces Pricing of Public Offering of Common Stock - GlobeNewswire (press release)HTG Molecular Diagnostics Announces Pricing of Public Offering of Common Stock - GlobeNewswire (press release)
globenewswire.com - January 19 at 5:44 AM
HTG Molecular Diagnostics Announces Pricing of Public Offering of Common StockHTG Molecular Diagnostics Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 19 at 5:44 AM
BRIEF-HTG Molecular Diagnostics Expects Q4 2017 Revenue of $7.6 Mln to $7.9 Mln- SEC FilingBRIEF-HTG Molecular Diagnostics Expects Q4 2017 Revenue of $7.6 Mln to $7.9 Mln- SEC Filing
www.reuters.com - January 17 at 11:18 AM
HTG Molecular Diagnostics (HTGM) Plans 10M Share Public Offering of Common StockHTG Molecular Diagnostics (HTGM) Plans 10M Share Public Offering of Common Stock
www.streetinsider.com - January 17 at 11:18 AM
HTG Molecular Diagnostics Announces Proposed Public Offering of Common StockHTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 17 at 11:18 AM
HTG Molecular Diagnostics (HTGM) Stock Rating Lowered by Zacks Investment ResearchHTG Molecular Diagnostics (HTGM) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - January 14 at 8:50 PM
HTG Molecular: Upside For This ~$3.50 Busted IPO? - Seeking AlphaHTG Molecular: Upside For This ~$3.50 'Busted IPO'? - Seeking Alpha
seekingalpha.com - January 13 at 3:37 PM
HTG Molecular Diagnostics (HTGM) Cut to Hold at Zacks Investment ResearchHTG Molecular Diagnostics (HTGM) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - January 5 at 11:48 PM
HC Wainwright Reiterates $6.00 Price Target for HTG Molecular Diagnostics (HTGM)HC Wainwright Reiterates $6.00 Price Target for HTG Molecular Diagnostics (HTGM)
www.americanbankingnews.com - January 5 at 8:44 PM
HTG Molecular Diagnostics (HTGM) Price Target Raised to $5.00HTG Molecular Diagnostics (HTGM) Price Target Raised to $5.00
www.americanbankingnews.com - January 5 at 4:22 PM
Zacks: HTG Molecular Diagnostics Inc (HTGM) Receives Average Recommendation of "Strong Buy" from BrokeragesZacks: HTG Molecular Diagnostics Inc (HTGM) Receives Average Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - January 5 at 3:10 PM
HTG Molecular Diagnostics (HTGM) Announces Prelim. Q4 Results and Provides Initial 2018 Revenue GuidanceHTG Molecular Diagnostics (HTGM) Announces Prelim. Q4 Results and Provides Initial 2018 Revenue Guidance
www.streetinsider.com - January 5 at 11:43 AM
Can HTG Molecular Diagnostics Inc (NASDAQ:HTGM) Improve Your Portfolio Returns?Can HTG Molecular Diagnostics Inc (NASDAQ:HTGM) Improve Your Portfolio Returns?
finance.yahoo.com - January 5 at 11:43 AM
Mid-Afternoon Market Update: Dow Rises Over 150 Points; L Brands Shares Plunge - NasdaqMid-Afternoon Market Update: Dow Rises Over 150 Points; L Brands Shares Plunge - Nasdaq
www.nasdaq.com - January 4 at 3:39 PM
HTG Molecular Diagnostics (HTGM) Announces Prelim. Q4 Results and Provides Initial 2018 Revenue Guidance - StreetInsider.comHTG Molecular Diagnostics (HTGM) Announces Prelim. Q4 Results and Provides Initial 2018 Revenue Guidance - StreetInsider.com
www.streetinsider.com - January 4 at 11:13 AM
HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue GuidanceHTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance
finance.yahoo.com - January 4 at 11:13 AM
ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 29, 2017ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 29, 2017
finance.yahoo.com - December 29 at 3:39 PM
BRIEF-HTG Molecular, Illumina Agreed To Third Development Plan Under Parties Amended & Restated Development & Supply AgreementBRIEF-HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement
www.reuters.com - December 27 at 8:19 PM
25 Stocks Moving In Wednesdays Mid-Day Session - Benzinga25 Stocks Moving In Wednesday's Mid-Day Session - Benzinga
www.benzinga.com - December 27 at 3:19 PM
Mid-Day Market Update: Energous Surges After Receiving FCC Certification For Wireless Charging; One Horizon ... - NasdaqMid-Day Market Update: Energous Surges After Receiving FCC Certification For Wireless Charging; One Horizon ... - Nasdaq
www.nasdaq.com - December 27 at 3:19 PM
HTG Moleculars Deal With Merck KGaA Provides Further Validation For EdgeSeq Technology - BenzingaHTG Molecular's Deal With Merck KGaA 'Provides Further Validation' For EdgeSeq Technology - Benzinga
www.benzinga.com - December 27 at 3:19 PM
Mid-Afternoon Market Update: Crude Oil Down 0.8%; Kazia Therapeutics Shares Spike HigherMid-Afternoon Market Update: Crude Oil Down 0.8%; Kazia Therapeutics Shares Spike Higher
feeds.benzinga.com - December 27 at 3:04 PM
Health Care Sector Update for 12/27/2017: KZIA, HTGM, GKOS, TRPX - NasdaqHealth Care Sector Update for 12/27/2017: KZIA, HTGM, GKOS, TRPX - Nasdaq
www.nasdaq.com - December 27 at 12:48 PM
A Peek Into The Markets: US Stock Futures Mostly Flat Ahead Of Consumer Confidence, Pending Home Sales Data - BenzingaA Peek Into The Markets: US Stock Futures Mostly Flat Ahead Of Consumer Confidence, Pending Home Sales Data - Benzinga
www.benzinga.com - December 27 at 12:48 PM
22 Stocks Moving In Wednesdays Pre-Market Session | Benzinga - Benzinga22 Stocks Moving In Wednesday's Pre-Market Session | Benzinga - Benzinga
www.benzinga.com - December 27 at 12:48 PM
Pre-Open Movers 12/27: (WATT) (HTGM) (NVFY) Higher; (ELY) (TSLA) Lower (more...) - StreetInsider.comPre-Open Movers 12/27: (WATT) (HTGM) (NVFY) Higher; (ELY) (TSLA) Lower (more...) - StreetInsider.com
www.streetinsider.com - December 27 at 12:48 PM
HTG Molecular Diagnostics Expands its Collaboration with Merck KGaA, Darmstadt, Germany - GlobeNewswire (press release)HTG Molecular Diagnostics Expands its Collaboration with Merck KGaA, Darmstadt, Germany - GlobeNewswire (press release)
globenewswire.com - December 27 at 12:48 PM
 HTG Molecular Diagnostics Inc (HTGM) Given $6.00 Average Target Price by Analysts HTG Molecular Diagnostics Inc (HTGM) Given $6.00 Average Target Price by Analysts
www.americanbankingnews.com - December 27 at 5:34 AM
HTG Molecular Diagnostics Expands its Collaboration with Merck KGaA, Darmstadt, GermanyHTG Molecular Diagnostics Expands its Collaboration with Merck KGaA, Darmstadt, Germany
finance.yahoo.com - December 26 at 9:08 PM
HTG Molecular Diagnostics to Participate in Corporate Access Event ... - GlobeNewswire (press release)HTG Molecular Diagnostics to Participate in Corporate Access Event ... - GlobeNewswire (press release)
globenewswire.com - December 22 at 11:34 AM
BRIEF-HTG Molecular Diagnostics And Unit Of QIAGEN Amended First Statement Of Work Under Master AgreementBRIEF-HTG Molecular Diagnostics And Unit Of QIAGEN Amended First Statement Of Work Under Master Agreement
www.reuters.com - December 20 at 3:38 PM
Form 8-K HTG MOLECULAR DIAGNOSTIC For: Dec 18 - StreetInsider.comForm 8-K HTG MOLECULAR DIAGNOSTIC For: Dec 18 - StreetInsider.com
www.streetinsider.com - December 20 at 11:27 AM
HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018 - NasdaqHTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018 - Nasdaq
www.nasdaq.com - December 20 at 11:27 AM
HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018
finance.yahoo.com - December 20 at 11:27 AM
ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 18, 2017ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 18, 2017
finance.yahoo.com - December 19 at 11:23 AM
Should You Be Content With HTG Molecular Diagnostics Inc’s (HTGM) 34.3% Earnings Growth?Should You Be Content With HTG Molecular Diagnostics Inc’s (HTGM) 34.3% Earnings Growth?
finance.yahoo.com - December 6 at 8:46 AM
ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 5, 2017ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 5, 2017
finance.yahoo.com - December 5 at 6:03 PM
Zacks: Analysts Set $6.00 Target Price for HTG Molecular Diagnostics, Inc. (HTGM)Zacks: Analysts Set $6.00 Target Price for HTG Molecular Diagnostics, Inc. (HTGM)
www.americanbankingnews.com - December 2 at 11:30 PM
HTG Molecular Diagnostics, Inc. (HTGM) Upgraded to Buy at Zacks Investment ResearchHTG Molecular Diagnostics, Inc. (HTGM) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - November 25 at 9:32 AM
Should You Be Concerned About HTG Molecular Diagnostics Inc’s (HTGM) Investors?Should You Be Concerned About HTG Molecular Diagnostics Inc’s (HTGM) Investors?
finance.yahoo.com - November 21 at 7:42 PM
ETFs with exposure to HTG Molecular Diagnostics, Inc. : November 20, 2017ETFs with exposure to HTG Molecular Diagnostics, Inc. : November 20, 2017
finance.yahoo.com - November 20 at 8:05 PM
HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017
finance.yahoo.com - November 11 at 10:03 AM
HTG Molecular Diagnostics (HTGM) CEO TJ Johnson on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaHTG Molecular Diagnostics' (HTGM) CEO TJ Johnson on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 8 at 8:38 PM

SEC Filings

HTG Molecular Diagnostics (NASDAQ:HTGM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

HTG Molecular Diagnostics (NASDAQ:HTGM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

HTG Molecular Diagnostics (NASDAQ HTGM) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.